132 related articles for article (PubMed ID: 31694772)
1. CDK12 Mutation in Advanced Prostate Cancer: A Marker for Clinical Subtype?
Wang X; Chen H; Luo J; Xie L
Eur Urol; 2020 Mar; 77(3):342-343. PubMed ID: 31694772
[No Abstract] [Full Text] [Related]
2. Prognostic and clinicopathological value of CDK12 mutation in prostate cancer: a meta-analysis.
Zhang W; Zhou L; Di J
Expert Rev Anticancer Ther; 2023 Feb; 23(2):207-216. PubMed ID: 36734254
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer.
Sartor O; Jang A; Ledet E
Oncologist; 2023 Nov; 28(11):e1127-e1128. PubMed ID: 37589230
[TBL] [Abstract][Full Text] [Related]
4. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".
Valle LF; Nickols NG; Yamoah K; Garraway IP; Maxwell KN; Lynch JA
Oncologist; 2023 Nov; 28(11):e1129-e1130. PubMed ID: 37706534
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer.
Maddison LA; Huss WJ; Barrios RM; Greenberg NM
Prostate; 2004 Mar; 58(4):335-44. PubMed ID: 14968434
[TBL] [Abstract][Full Text] [Related]
6.
Lotan TL; Antonarakis ES
Clin Cancer Res; 2021 Jan; 27(2):380-382. PubMed ID: 33199495
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation.
Chen HH; Wang YC; Fann MJ
Mol Cell Biol; 2006 Apr; 26(7):2736-45. PubMed ID: 16537916
[TBL] [Abstract][Full Text] [Related]
8.
Cancer Discov; 2018 Sep; 8(9):1055. PubMed ID: 30006379
[TBL] [Abstract][Full Text] [Related]
9. CDK12 Gene Alterations in Prostate Cancer: Present, but Clinically Actionable?
Marciscano AE; Barbieri CE
Eur Urol; 2020 Nov; 78(5):680-681. PubMed ID: 32381460
[No Abstract] [Full Text] [Related]
10. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
Hobeika AC; Subramaniam PS; Johnson HM
Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
[TBL] [Abstract][Full Text] [Related]
11. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
[TBL] [Abstract][Full Text] [Related]
12. [Function of CDK12 in Tumor initiation and progression and its clinical consequences].
Vrábel D; Svoboda M; Navrátil J; Kohoutek J
Klin Onkol; 2014; 27(5):340-6. PubMed ID: 25312711
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.
Knight-Krajewski S; Welsh CF; Liu Y; Lyons LS; Faysal JM; Yang ES; Burnstein KL
Oncogene; 2004 Jul; 23(32):5513-22. PubMed ID: 15077174
[TBL] [Abstract][Full Text] [Related]
14. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats.
Chen Y; Robles AI; Martinez LA; Liu F; Gimenez-Conti IB; Conti CJ
Cell Growth Differ; 1996 Nov; 7(11):1571-8. PubMed ID: 8930407
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
Hall M; Peters G
Adv Cancer Res; 1996; 68():67-108. PubMed ID: 8712071
[No Abstract] [Full Text] [Related]
16. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
[TBL] [Abstract][Full Text] [Related]
17. Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression.
Taneja SS; Ha S; Garabedian MJ
J Cell Biochem; 2001; 84(1):188-99. PubMed ID: 11746527
[TBL] [Abstract][Full Text] [Related]
18. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
19. Role and therapeutic potential of CDK12 in human cancers.
Chilà R; Guffanti F; Damia G
Cancer Treat Rev; 2016 Nov; 50():83-88. PubMed ID: 27662623
[TBL] [Abstract][Full Text] [Related]
20. CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability.
Choi SH; Martinez TF; Kim S; Donaldson C; Shokhirev MN; Saghatelian A; Jones KA
Genes Dev; 2019 Apr; 33(7-8):418-435. PubMed ID: 30819820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
